Investigation of Candida auris in Tanta University Hospitals, Egypt | ||||
| Egyptian Journal of Medical Microbiology | ||||
| Article 12, Volume 31, Issue 1, January 2022, Page 83-88 PDF (249.03 K) | ||||
| Document Type: New and original researches in the field of Microbiology. | ||||
| DOI: 10.21608/ejmm.2022.211980 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Sara Y. Maxwell 1; Marwa Abd-Elmonsef  2
| ||||
| 1Lecturer in Medical Microbiology & Immunology Department, Faculty of Medicine, Tanta University, Egypt | ||||
| 2Assistant Professor in Medical Microbiology & Immunology Department, Faculty of Medicine, Tanta University, Egypt | ||||
| Abstract | ||||
| Background: Candida auris is an emerging multidrug-resistant (MDR) fungus of global significance. It causes invasive life-threatening infections associated with treatment failure. Objectives: To investigate the occurrence of C. auris species in Tanta University Hospitals, and its susceptibility profile to different antifungal agents. Methodology: Candida was isolated from different specimens. Screening for C. auris was performed using CHROMagar Candida medium. Species identification and antifungal susceptibility testing were performed by VITEK2 system. Molecular confirmation was done by PCR. Results: Out of 414 Candida isolates, 295 (71.3%) isolates were C. albicans, 48 (11.6%) were C. tropicalis, 42 (10.2%) were C. parapsilosis, 20 (4.8%) were C. krusei, 8 (1.9%) were C. glabrata and one (0.2%) isolate was C. haemulonii. Two isolates were MDR. No C. auris was identified by VITEK2 system or by PCR. Conclusion: No C. auris has been detected in Tanta University HHHHHHospitals. Nationwide studies are required for early detection of this superbug and limit its spread. | ||||
| Keywords | ||||
| Candida; auris; CHROMagar; VITEK2; PCR | ||||
|
Statistics Article View: 448 PDF Download: 501 |
||||
